Owners, management and financials
CVR: 20830131
Secondary names: LABKEMI DENMARK A/S, MILLIPORE A/S
Previous names: KM 156 A/S, LABKEMI DENMARK A/S, SIGMA-ALDRICH DENMARK ApS
DKK 1,748,796,583
Revenue
Net result: DKK 79,492,665
Merck Life Science N.V (100%)
CVR · view owners
Janecke Stokkebokjær Lundring
Board: Anders Gerner Petersen (chair) and 2 members
CVR · view management
Active
Founded 20 January 1998
CVR · view overview
24 employees
CVR · 2026
Director role ended: Montserrat Jansa Rodriguez
CVR · 01/01/2026
View the full event history
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.
Source: annual report 2025, Danish Business Authority
Merck Life Science A/S demonstrates a solid financial health with a consistent upward trajectory in revenue and profit over the past five years. Revenue increased from 1,008.6 million DKK in 2021 to 1,748.8 million DKK in 2025, while profit rose from 37.7 million DKK to 79.5 million DKK in the same period, indicating strong growth and improving profitability. The company's equity has also shown a positive trend, reaching 226.1 million DKK in 2025, although it experienced a slight dip in 2023. With a growing revenue base and improving profit margins, Merck Life Science A/S is well-positioned within the machinery and equipment wholesale industry, although attention should be paid to maintaining equity levels to support future growth.
AI-generated summary · Generated 17/06/2026
Selskabets formål er at drive handel samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.7 mia. | 79.5 mio. | 322.5 mio. | 226.1 mio. | 22 | |
| 202401/01/2024 – 31/12/2024 | 1.5 mia. | 66.7 mio. | 298.3 mio. | 216.6 mio. | 23 | |
| 202301/01/2023 – 31/12/2023 | 1.4 mia. | 73.6 mio. | 322.7 mio. | 239.9 mio. | 24 | |
| 202201/01/2022 – 31/12/2022 | 1.3 mia. | 46 mio. | 233.2 mio. | 166.2 mio. | 20 | |
| 202101/01/2021 – 31/12/2021 | 1 mia. | 37.7 mio. | 249.9 mio. | 214.7 mio. | 16 | |
| 202001/01/2020 – 31/12/2020 | 768.2 mio. | 41.3 mio. | 237.3 mio. | 177 mio. | 16 | |
| 201901/01/2019 – 31/12/2019 | - | 27.4 mio. | 181.7 mio. | 135.7 mio. | 9 | |
| 201801/01/2018 – 31/12/2018 | - | 16.7 mio. | 87.3 mio. | 67.1 mio. | 14 | |
| 201701/01/2017 – 31/12/2017 | - | 8.6 mio. | 76.3 mio. | 50.4 mio. | 16 | |
| 201601/01/2016 – 31/12/2016 | - | 6.2 mio. | 70.6 mio. | 41.7 mio. | 17 | |
| 201501/01/2015 – 31/12/2015 | - | 7.4 mio. | 48.7 mio. | 35.5 mio. | 17 | |
| 201401/01/2014 – 31/12/2014 | - | 3.9 mio. | 47.4 mio. | 28.1 mio. | - | |
| 201301/01/2013 – 31/12/2013 | - | 4.2 mio. | 38.2 mio. | 24.2 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 25.8 mio. | 4.3 mio. | 40.1 mio. | 20 mio. | - |
Compared to 1.737 companies in Engroshandel med andre maskiner og andet udstyr
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Merck Life Science A/S is 20830131.
Merck Life Science A/S is owned by Merck Life Science N.V.
The management of Merck Life Science A/S consists of Janecke Stokkebokjær Lundring.
The board of Merck Life Science A/S consists of Anders Gerner Petersen, Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka, with Anders Gerner Petersen as chair.
In 2025, Merck Life Science A/S reported revenue of DKK 1,748,796,583.
Merck Life Science A/S had 24 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Merck Life Science A/S has published its annual report for 2025. Revenue came to DKK 1,748,796,583, and the net result was DKK 79,492,665.
As of January 1, 2026, Janecke Stokkebokjær Lundring has joined the board of directors of Merck Life Science A/S.
As of January 1, 2026, Montserrat Jansa Rodriguez has left the board of directors of Merck Life Science A/S.
As of January 1, 2026, Janecke Stokkebokjær Lundring is registered as adm. dir. of Merck Life Science A/S.
As of January 1, 2026, Montserrat Jansa Rodriguez has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2024. Revenue came to DKK 1,536,249,249, and the net result was DKK 66,730,278.
Merck Life Science A/S has published its annual report for 2023. Revenue came to DKK 1,398,642,419, and the net result was DKK 73,609,980.
Merck Life Science A/S has won the tender "Udbud af rammeaftale vedr. avancerede kemikalier" issued by Aalborg Universitet.
Merck Life Science A/S has published its annual report for 2022. Revenue came to DKK 1,256,087,140, and the net result was DKK 46,001,362.
As of May 11, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Merck Life Science A/S.
As of May 11, 2023, KPMG P/S has stepped down as auditor of Merck Life Science A/S.
As of March 1, 2023, Anders Gerner Petersen has joined the board of directors of Merck Life Science A/S.
As of March 1, 2023, David Mouyal has left the board of directors of Merck Life Science A/S.
As of October 1, 2022, Montserrat Jansa Rodriguez has joined the board of directors of Merck Life Science A/S.
As of October 1, 2022, Montserrat Jansa Rodriguez is registered as adm. dir. of Merck Life Science A/S.
As of September 30, 2022, Enrique Álvarez Fernández has left the board of directors of Merck Life Science A/S.
As of September 30, 2022, Enrique Álvarez Fernández has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2021. Revenue came to DKK 1,008,595,819, and the net result was DKK 37,723,717.
Merck Life Science A/S has published its annual report for 2020. Revenue came to DKK 768,192,545, and the net result was DKK 41,276,750.
As of July 1, 2021, is registered as an owner of Merck Life Science A/S with an ownership share of 100%.
Merck Life Science A/S has published its annual report for 2019. Gross profit came to DKK 53,447,114, and the net result was DKK 27,387,479.
As of April 29, 2020, David Mouyal has joined the board of directors of Merck Life Science A/S.
As of April 29, 2020, Jeanette Sandholmen has left the board of directors of Merck Life Science A/S.
On November 4, 2019, the company changed its name from SIGMA-ALDRICH DENMARK A/S to Merck Life Science A/S.
As of June 1, 2019, Enrique Álvarez Fernández has joined the board of directors of Merck Life Science A/S.
As of June 1, 2019, Renée Christine Tunold has left the board of directors of Merck Life Science A/S.
As of June 1, 2019, Enrique Álvarez Fernández is registered as adm. dir. of Merck Life Science A/S.
As of June 1, 2019, Tiina Marjatta Puhakka has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2018. Gross profit came to DKK 26,897,123, and the net result was DKK 16,709,359.
On April 10, 2019, the company changed its name from SIGMA-ALDRICH DENMARK ApS to SIGMA-ALDRICH DENMARK A/S.
As of April 9, 2019, Jeanette Sandholmen has joined the board of directors of Merck Life Science A/S.
As of April 9, 2019, Tiina Marjatta Puhakka has joined the board of directors of Merck Life Science A/S.
As of April 8, 2019, Jeanette Sandholmen has left the board of directors of Merck Life Science A/S.
As of April 8, 2019, Tiina Marjatta Puhakka has left the board of directors of Merck Life Science A/S.
As of December 3, 2018, Jeanette Sandholmen has joined the board of directors of Merck Life Science A/S.
As of December 3, 2018, Renée Christine Tunold has joined the board of directors of Merck Life Science A/S.
As of December 3, 2018, Hans Christopher Elers Koch has left the board of directors of Merck Life Science A/S.
As of November 15, 2018, Tiina Marjatta Puhakka is registered as adm. dir. of Merck Life Science A/S.
As of November 15, 2018, Hans Christopher Elers Koch has stepped down as adm. dir. of Merck Life Science A/S.
As of September 14, 2018, Hans Christopher Elers Koch has joined the board of directors of Merck Life Science A/S.
As of September 14, 2018, Lars Ohrberg has left the board of directors of Merck Life Science A/S.
As of September 14, 2018, Hans Christopher Elers Koch is registered as adm. dir. of Merck Life Science A/S.
As of September 14, 2018, Lars Ohrberg has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2017. Gross profit came to DKK 21,328,958, and the net result was DKK 8,644,278.
As of November 6, 2017, Tiina Marjatta Puhakka has joined the board of directors of Merck Life Science A/S.
As of November 6, 2017, Lutz Schraishuhn has left the board of directors of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2016. Gross profit came to DKK 20,262,564, and the net result was DKK 6,204,236.
Merck Life Science A/S has published its annual report for 2015. Gross profit came to DKK 34,274,758, and the net result was DKK 7,405,593.
As of January 1, 2016, Franklin Devoe Wicks Jr has left the board of directors of Merck Life Science A/S.
As of September 15, 2015, Lutz Schraishuhn has joined the board of directors of Merck Life Science A/S.
As of September 15, 2015, Søren Høegh has left the board of directors of Merck Life Science A/S.
As of September 15, 2015, Lars Ohrberg is registered as adm. dir. of Merck Life Science A/S.
As of September 15, 2015, Søren Høegh has stepped down as director of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2014. Gross profit came to DKK 27,527,082, and the net result was DKK 3,885,492.
As of September 8, 2014, KPMG P/S has been appointed auditor of Merck Life Science A/S.
As of September 8, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2013. Gross profit came to DKK 25,961,931, and the net result was DKK 4,236,623.
Merck Life Science A/S has published its annual report for 2012. Revenue came to DKK 25,846,000, and the net result was DKK 4,273,000.
On October 11, 2012, the company changed its name from LABKEMI DENMARK A/S to SIGMA-ALDRICH DENMARK ApS.
As of November 13, 2009, EY Godkendt Revisionspartnerselskab has been appointed auditor of Merck Life Science A/S.
As of February 5, 2009, REVISIONSKONTORET I AARHUS, AKTIESELSKAB has stepped down as auditor of Merck Life Science A/S.
As of July 29, 2002, REVISIONSKONTORET I AARHUS, AKTIESELSKAB has been appointed auditor of Merck Life Science A/S.
As of July 29, 2002, has stepped down as auditor of Merck Life Science A/S.
As of May 31, 1999, Franklin Devoe Wicks Jr has joined the board of directors of Merck Life Science A/S.
As of May 31, 1999, Tom Tallarco has left the board of directors of Merck Life Science A/S.
On June 5, 1998, the company changed its name from KM 156 A/S to LABKEMI DENMARK A/S.
As of June 4, 1998, has been appointed auditor of Merck Life Science A/S.
As of June 4, 1998, CJ Partnership I/S has stepped down as auditor of Merck Life Science A/S.
As of June 4, 1998, Søren Høegh has joined the board of directors of Merck Life Science A/S.
As of June 4, 1998, Lars Ohrberg has joined the board of directors of Merck Life Science A/S.
As of June 4, 1998, Tom Tallarco has joined the board of directors of Merck Life Science A/S.
As of June 4, 1998, Michael Egede Budtz has left the board of directors of Merck Life Science A/S.
As of June 4, 1998, Kurt Skovlund has left the board of directors of Merck Life Science A/S.
As of June 4, 1998, Henrik Møgelmose has left the board of directors of Merck Life Science A/S.
As of June 4, 1998, Vagn Thorup has left the board of directors of Merck Life Science A/S.
As of June 4, 1998, Søren Høegh is registered as director of Merck Life Science A/S.
As of June 4, 1998, Jørgen Byriel has stepped down as director of Merck Life Science A/S.
As of January 20, 1998, CJ Partnership I/S has been appointed auditor of Merck Life Science A/S.
As of January 20, 1998, Michael Egede Budtz has joined the board of directors of Merck Life Science A/S.
As of January 20, 1998, Kurt Skovlund has joined the board of directors of Merck Life Science A/S.
As of January 20, 1998, Henrik Møgelmose has joined the board of directors of Merck Life Science A/S.
As of January 20, 1998, Vagn Thorup has joined the board of directors of Merck Life Science A/S.
As of January 20, 1998, Jørgen Byriel is registered as director of Merck Life Science A/S.
Merck Life Science A/S was founded on January 20, 1998.
Companies in the same industry and area
CVR 45848752
CVR 38548905
CVR 12478097
CVR 17198238
CVR 39692635
